NCT07355465

Brief Summary

Molar-Incisor Hypo mineralization (MIH) was first described in 2001 as a developmental enamel defect . It is a condition in which the enamel of at least one first primary molar is affected with a qualitative defect causing abnormal translucency appearing as demarcated opacities; The permanent incisors and second primary molars can also be affected . MIH has adverse consequences on the oral health and child's quality of life. It increases the risk of caries, discomfort and teeth sensitivity . MIH management comprises a variety of treatment options ranging from total caries removal to the polar opposite treatment option of no caries removal and non-invasive methods used to prevent caries progression . Dental caries prediction and prevention are now more important than dental caries diagnosis and treatment. Recently, the reasons for repairing dental cavities have been narrowed, and caries prevention is being used to reduce caries . Salvadora persica, commonly known as Miswak was used as a toothbrush for many years among many countries . It was reported to have a significant effect on oral health and caries prevention .Other studies have found a consistent link between the use of Miswak and a reduction in oral bacteria. However, a comprehensive assessment of using Miswak in the treatment and control of MIH among young children has yet to be conducted. Therefore, the aim of this clinical trial is to assess the effect of SalvadoraPersica and fluoridated toothpaste on controlling hypersensitivity and preventing caries among children with MIH in primary schools. Additionally, this trial will evaluate the shade of the hypo-mineralized enamel before and after using SalvadoraPersica and fluoridated toothpaste

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
13mo left

Started Jan 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jan 2026May 2027

First Submitted

Initial submission to the registry

November 20, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 21, 2026

Completed
8 days until next milestone

Study Start

First participant enrolled

January 29, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2027

Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

11 months

First QC Date

November 20, 2025

Last Update Submit

January 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • To Assess the effect of Salvadora Persica on the color of MIH-affected teeth compared to brushing with fluoridated toothpaste

    The VITA Easyshade® advance spectrophotometer (VITA Zahnfabrik, Bad Sackingen, Germany) will be used to assess the color of MIH-affected permanent incisors and the adjacent sound enamel

    Before intervention as a baseline reading (T0), one month (T1), three months later (T2), and six months later (T3)

Secondary Outcomes (1)

  • the effectiveness of Salvadora Persica on the hypersensitivity of MIH-affected teeth compared to brushing with fluoridated toothpaste

    Before intervention as a baseline reading (T0), one month (T1), three months later (T2), and six months later (T3).

Study Arms (2)

Salvadora Persica (Miswak)

EXPERIMENTAL

Intervention Group: Participants in this group will be provided with Salvadora persica (miswak) sticks and receive training on the correct technique for its use. Miswak sticks, uniform in length and width, supplied fresh from Jeddah Central Market, Saudi Arabia, to the subjects in the test group. In this group, subjects will be instructed to brush with the miswak using the rolling technique, advised to use it three times a day under a parent's supervision, and shown how to keep it fresh by cutting off the edge of the miswak every day and storing it in the refrigerator at night.

Other: Salvadora persica (miswak)

Fluoridated Toothpaste Group

ACTIVE COMPARATOR

Control Group: Participants in this group were instructed to use only fluoridated toothpaste as part of their oral hygiene routine. Oral hygiene instructions will be given for both groups. Modified bass technique for tooth brushing twice daily, 10 seconds per quadrant, with a 1450 ppm fluoride concentration

Device: Fluoridated Toothpaste

Interventions

Salvadora persica (miswak) has been traditionally used as a natural toothbrush across various cultures for centuries. It contains several biologically active compounds, including fluoride, silica,

Salvadora Persica (Miswak)

Participants will use fluoridated toothpaste (1450 ppm fluoride) three times daily under parental supervision for 9 months to compare its effects with Nano-hydroxyapatite.

Fluoridated Toothpaste Group

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Healthy children with age ranged between 6-12 years old
  • Presence of at least one first permanent molar and incisor diagnosed with MIH.
  • The MIH-affected teeth will have a clinical presentation of white, creamy, yellow, or brown demarcated opacities

You may not qualify if:

  • Medically compromised children.
  • Unwillingness to participate or be randomly assigned to the study groups.
  • Receiving treatment for controlling MIH other than fluoride application

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Molar Hypomineralization

Condition Hierarchy (Ancestors)

Dental Enamel HypomineralizationDevelopmental Defects of EnamelTooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

November 20, 2025

First Posted

January 21, 2026

Study Start

January 29, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

May 30, 2027

Last Updated

January 21, 2026

Record last verified: 2026-01